References
- Perry, Caroline M. (2012). Azilsartan medoxomil : A review of its use in Hypertension Clinical Drug Investigation 32(9): 621–639.
- Baker, W.L., White, W.B., (2011). Azilsartan medoxomil: a new angiotensin II receptor antagonist for treatment of hypertension. Annals of Pharmacotherapy 45(12): 1506–1515. doi: 10.1345/aph.1Q468
- Zhao, Chun-yan., Wang, Jing-jing., Liu, Yang., Zhao, Ying-hui., Dai, Jin-mei., Zhongguo Xinyao Zazhi. (2011). Pharmacology and clinical evaluation of edarbi, a new drug for the treatment of cardiovascular disease. 20(19): 1831–1834.
- Jones, Jocelyn D., Jackson, Sylvia H., (2013). Colquitt, Charlie. From Research Reports in Clinical Cardiology 4: 125–133. doi: 10.2147/RRCC.S34791
- Pradeepthi, J., Masthanamma, S.K., Alekhya, G. (2013). A validated spectrophotometric method for determination of Azilsartan medoxomil in pharmaceutical dosage form. Journal of Scientific Research in Pharmacy. 2(4): 7–10.
- Gorla, Raja., Nagaraju, Ch., Sreenivasulu, B., Sreenivas, N. (2013). New simple UV spectrophotometric method for determination of azilsartan medoxomil in bulk and pharmaceutical dosage forms. International Journal of Research in Pharmaceutical and Biomedical Sciences. 4(4): 1133–1137.
- Ebeid Walid, M., Elkady, Ehab F., El-Zaher, Asmaa A., El-Bagary, Ramzia I., Patonay Gabor. (2014). Spectrophotometric and spectrofluorimetric studies on azilsartan medoxomil and chlorthalidone to be utilized in their determination in pharmaceuticals.Analytical chemistry insights. 933–40.
- Vekariya, P.P., Joshi, H.S. (2013). Development and validation of RP-HPLC method for Azilsartan Medoxomil Potassium quantitation in human plasma by solid phase extraction procedure. ISRN Spectroscopy. 572–170, 7 pp.
- Naazneen, S., Sridevi, A. (2014). Stability-indicating RP-HPLC method for the simultaneous estimation of Azilsartan medoxomil and chlorthalidone in solid dosage forms. International Journal of Pharmacy and Pharmaceutical Sciences. 6(6): 226–243.
- Madhu Babu Kasimala, Bikshal Babu Kasimala. (2012). Reverse Phase-HPLC Method Development and Validation for the Simultaneous Estimation of Azilsartan Medoxomil and Chlortalidone in Pharmaceutical Dosage Forms. Journal of Atoms and Molecules, 2(1): 117–126.
- Q2 (R1), (2005). ICH, “Validation of Analytical Procedures: Text and Methodology”.
- Q1A(R2), 2005. ICH, “Stability Testing of New Drug Substances and Products”.
- US FDA Guidance, (2000). “Analytical Procedures and Methods Validation,”
- Official Methods of Analysis, 15th Ed.(1990). Association of Offical Analytical Chemists International, Arlington, VA, XVII.
- Validation of Compendial Methods (1225). The United States Pharmacopeia.
- United states pharmacopeial Convention, 36th ed. (2012). The United States Pharmacopoeia, Rockville, MD.
- Guideline for submitting samples, (1987). Analytical Data for Methods Validation, US Food and Drug Administration.
- Bliesner, D.M. (2006). “Validating Chromatographic Methods: A Practical Guide.
- Baertschi, K. Alsante, S.W. and Reed, R.A. (2005). Pharmaceutical Stress Testing: Predicting Drug Degradation,” Informa Healthcare.